INSERM UMR 1231, Génétique des Anomalies du Développement, Université́ de Bourgogne Franche-Comté́, Dijon, France.
FHU-TRANSLAD, Fédération Hospitalo-Universitaire Médecine Transrationnelle et Anomalies du Développement, CHU Dijon Bourgogne, Dijon, France.
Eur J Hum Genet. 2022 Aug;30(8):967-975. doi: 10.1038/s41431-022-01117-7. Epub 2022 May 16.
Prenatal exome sequencing could be complex because of limited phenotypical data compared to postnatal/portmortem phenotype in fetuses affected by multiple congenital abnormalities (MCA). Here, we investigated limits of prenatal phenotype for ES interpretation thanks to a blindly reanalysis of postmortem ES data using prenatal data only in fetuses affected by MCA and harboring a (likely)pathogenic variant or a variant of unknown significance (VUS). Prenatal ES identified all causative variant previously reported by postmortem ES (22/24 (92%) and 2/24 (8%) using solo-ES and trio-ES respectively). Prenatal ES identified 5 VUS (in four fetuses). Two of them have been previously reported by postmortem ES. Prenatal ES were negative for four fetuses for which a VUS were diagnosed after autopsy. Our study suggests that prenatal phenotype is not a limitation for implementing pES in the prenatal assessment of unsolved MCA to personalize fetal medicine and could influence indication of postmortem examination.
产前外显子组测序可能比较复杂,因为与受多种先天性异常(MCA)影响的胎儿的产后/死后表型相比,其表型数据有限。在这里,我们仅使用受 MCA 影响且携带(可能)致病性变异或意义不明的变异(VUS)的胎儿的产前数据,对死后外显子组数据进行盲目重新分析,以研究产前表型对 ES 解释的局限性。产前外显子组测序鉴定了先前由死后外显子组测序报告的所有致病变异(分别使用 solo-ES 和 trio-ES 鉴定 22/24 例(92%)和 2/24 例(8%))。产前外显子组测序在 4 例胎儿中鉴定出 5 个 VUS。其中 2 个在死后外显子组测序中已有报道。对于另外 4 例胎儿,尸检后诊断为 VUS,产前外显子组测序结果为阴性。我们的研究表明,产前表型并不是在未解决的 MCA 产前评估中实施 pES 以实现胎儿医学个体化的限制,并且可能会影响死后检查的指征。